Overview
Alnylam (Nasdaq: ALNY) is delivering on a bold vision to turn scientific possibility into reality with a robust RNA interference (RNAi) therapeutics platform. As the pioneer in RNAi and the leading RNAi therapeutics company, we have always been uncompromisingly dedicated to translating breakthrough science into transformational medicines to help as many people as possible. Long focused on rare and genetic diseases; our scientific advances are now allowing us to bring the power of RNAi therapeutics to more prevalent diseases. As a result, we are beginning to recognize the full potential of this new class of medicines.
Alnylam is committed to its journey to becoming a top 5 independent, global biopharma company. We are already admired and recognized for our dedication to patients, a company culture that empowers people to do their best work, track record of scientific innovation, social responsibility, and commercial excellence.
Founded in 2002 and headquartered in Cambridge, Mass., Alnylam has over 1,650 employees at work across the globe. We seek smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted” to our mission. Thanks to the commitment of every employee globally, Alnylam is proud to have been recognized as one of Fast Company’s 2021 Best Workplaces for Innovators, a Science Magazine Top Employer three years in a row (2019-2021), a Boston Globe Top Places to Work seven years in a row (2015-2021), a Great Place to Work in Asia, Japan, Brazil, the U.K., Germany, Spain, Netherlands, Italy, France and Switzerland, Seramount’s 100 Best Companies (formerly Working Mother 100 Best Companies) and Best Companies for Dads, Bloomberg’s Gender Equality Index two years in a row (2021-2022), among others. At Alnylam, we are committed to fostering a diverse, equitable, and inclusive work environment, culture, and workforce, and we support several Employee Resource Networks.
The Medical Science Liaison is a field-based scientific and clinical expert that strategically supports the medical and scientific objectives of Alnylam’s investigational programs. They will be accountable for communicating the science and clinical application of RNAi to Healthcare Practitioners (HCPs). In addition, MSLs are expected to build strong cross-functional relationships with colleagues in Medical Affairs, Clinical Research, R&D, Patient Advocacy, and Commercial Operations while maintaining full compliance with all relevant company, industry, legal, and regulatory requirements.
Medical Affairs
Medical Affairs International TTR and Japan stands for integrity through unbiased, objective and balanced medical-scientific dialogs with the medical community. It plays a strategic role in a matrix of major responsibilities.
Summary Of Key Responsibilities
- Subject matter expert in the field of ATTR Polyneuropathy and Cardiomyopathy
- Keep up to date on scientific and clinical developments in the therapeutic areas in which Alnylam operates.
- Establish and maintain relationships with medical experts and healthcare professionals (HCPs) to create a better understanding of the company’s products and increase product awareness.
- Lead medical-scientific engagements with medical experts and implement clinical and educational strategies.
- Respond to unsolicited medical enquiries and provide clinical and scientific support for HCPs, including answering questions about products, drug interactions, side effects, and other related issues.
- Provide medical information (including sharing the insights gained in medical-scientific conversations with HCPs) to internal stakeholders.
- Support the efforts of patient advocacy groups and educational foundations.
- Provide medical and scientific input into the planning and execution of advisory boards and HCP educational meetings (including congresses of medical professional societies) and additional medical-scientific background where requested.
- Coordinate required medical, legal, and regulatory review and approval of all field documents for distribution or presentation.
- The job requires 60-70% travel.
Qualifications
- Ph.D., PharmD. or MD strongly preferred.
- Prior experience in the fields of neurology and cardiology strongly preferred.
- A minimum of five years experience in Pharma Medical Affairs or related functions. MSL experience, at least for three years strongly preferred.
- Proven basic science and clinical background to enable engagement with Health Care Professionals in a scientifically meaningful exchange.
- Experience in clinical research, patient recruitment, investigator-sponsored trials.
- Publication experience.
- Experience in medical education and medical expert engagement.
- Multi-lingual capability with business fluency in English preferred.
- Excellent communication skills; oral and written, including presentation skills to effectively communicate evidence-based scientific information.
- Hard-working, energetic, and passionate about making a meaningful difference for patients and caregivers.
- An unwavering commitment to upholding the highest ethical, legal, regulatory, and scientific standards.
Alnylam Pharmaceuticals is an EEO employer committed to an exciting, diverse, and enriching work environment. 
